![](http://investorshub.advfn.com/images/default_ih_profile2_4848.jpg?cb=0)
Friday, February 05, 2021 12:10:52 AM
GEM gets 7.5%+ $ of the NRXP deal when it closes and lots of stock.
GEM financed (1.3B, - 37% of OS) RLF for development of RLF-100, Trials and Patent.
GEM wants $$$ for their efforts... NRXP/RLFACER on the NASDAQ, IMO... Money talks, the RLF-100 Patent Rocks, SPAC wont balk.
VANSBIT, SEE THE RLFNRX PR 2-4-21.?.?.
https://moneymidnight.com/2021/02/rlftf-stock-relief-therapeutics-partner-neurorx-brpa-to-begin-phase-2-3-inhaled-zyesami-covid-19-study/
All development costs under the agreement are paid by Relief, providing NeuroRx with non dilutive development capital through drug approval"
Zyesami" Relief also holds a patent issued in the United States and various other countries covering potential formulations of RLF-100TM"
FEATURED North Bay Resources Acquires Mt. Vernon Gold Mine, Sierra County, California, with Assays up to 4.8 oz. Au per Ton • Jul 18, 2024 9:00 AM
VAYK Expects Revenue from First Airbnb Property Starting from August • VAYK • Jul 18, 2024 9:00 AM
Nightfood Holdings Signs Letter of Intent for All-Stock Acquisition of CarryOutSupplies.com • NGTF • Jul 17, 2024 1:00 PM
Kona Gold Beverages Reaches Out to Largest Debt Holder for Debt Purchase Negotiation • KGKG • Jul 17, 2024 9:00 AM
Avant Technologies Welcomes Back Former CEO with Eye Toward Future Growth and Expansion • AVAI • Jul 17, 2024 8:00 AM
HealthLynked Expands Telemedicine Nationwide • HLYK • Jul 17, 2024 8:00 AM